Winfield Associates’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-165
Closed -$4K 512
2017
Q4
$4K Buy
+165
New +$3.42K ﹤0.01% 562
2017
Q3
Sell
-80
Closed -$2K 870
2017
Q2
$2K Buy
80
+30
+60% +$654 ﹤0.01% 704
2017
Q1
$1K Hold
50
﹤0.01% 692
2016
Q4
$1K Hold
50
﹤0.01% 657
2016
Q3
$1K Buy
50
+20
+67% +$402 ﹤0.01% 635
2016
Q2
$1K Buy
+30
New +$565 ﹤0.01% 636

Other funds holding PTEN

Winfield Associates's PTEN Position: Q1 2018 in Review

Winfield Associates sold out of Patterson-UTI (PTEN) in Q1 2018, closing a stake of 165 shares — an estimated $4K sold.

Winfield Associates first reported a position in PTEN in Q2 2016 and held it in 6 quarters. The position peaked at $4K in Q4 2017. 327 funds tracked by Wall St. Rank hold PTEN as of Q1 2018.

  • Winfield Associates reported no remaining Patterson-UTI position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 165 Patterson-UTI shares in Q1 2018, an estimated $4K.
  • Winfield Associates first reported a position in Patterson-UTI in Q2 2016 and held it in 6 quarters.
  • Winfield Associates's Patterson-UTI position peaked at $4K in Q4 2017.
  • 327 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.